Dr. Md. Faiyazuddin is a University Professor (Pharmaceutics) and Formerly Dean, Research & Development of Al – Karim University, INDIA. His role is to oversee all research activities (PhD, PG) in the university and to promote high-quality research addressing social issues in coordination with various national and international stakeholders.
He earned an ‘Executive Degree in Strategic Leadership Management’ from the Jacobs-Abbey Global Institute for Leadership Studies, Woodbridge, USA and in recognition of his work, he was nominated as a Fellow member of the prestigious George Washington University USA (2019-2023), British Society of Nanomedicine UK (Lifetime), International Society of Aerosol in Medicine USA (2018-2021), Institute of Nanotechnology UK (2014-2023).
Prof. Faiyazuddin attracted a research grant and has made path-breaking contributions, particularly in Cancer and Respiratory Nanotechnology. Artificial Intelligence in Drug Delivery, Cancer Nanomedicine and Respiratory Nano
RESEARCH, TEACHING, or OTHER INTERESTS
Pharmacology, Toxicology and Pharmaceutics, Pharmaceutical Science, Drug Discovery
Computational identification of Terminalia arjuna phytochemicals as potential 3α-HSD3 inhibitors Md. Abdullah Al Mashud, Md. Abdur Rahman, Ajoy Kumer, Suraya Rahman, Mossadaque Azmain Awon, Thomas J. Webster, S. Gowri, Faiyaz Shakeel, Md. Faiyazuddin Scientific Reports, 2026 3α-Hydroxysteroid dehydrogenase type 3 (3α-HSD3) is a key steroid-metabolizing enzyme involved in the regulation of intratumoral androgen and estrogen levels, predominantly in estrogen receptor-positive (ER⁺) MCF-7 breast cancer cells. Its dysregulation influences proliferation, survival, and resistance to hormone-based therapy. The main goal of this study is to identify potential natural inhibitors of 3α-HSD3 from Terminalia arjuna phytoconstituents to modulate MCF-7 breast cancer cell proliferation. A panel of nine phytochemicals were evaluated through molecular docking, ADMET profiling, HOMO-LUMO energy gap analysis, and prediction of activity spectra for substances (PASS) to assess their drug-likeness and preliminary activity. Subsequently, molecular dynamics (MD) simulations were performed on top candidates to explore the structural stability and interaction dynamics of protein-ligand complexes. The selected compounds exhibited favorable docking scores against 3α-HSD3, with Luteolin(CMP1), Leucocyanidin(CMP2), Gallic Acid(CMP3), and Ellagic Acid(CPM4) forming stable hydrogen bonds with key active site residues. This study showed that the top four compounds may serve as potential 3α-HSD3 inhibitors of breast cancer, warranting further in vivo validation.
Reprogramming the pancreatic tumor microenvironment using smart stem cells: A new frontier in cancer therapy Tahir Basir Khan, Neeraj Choudhary, Sahil Sharma, Dinesh Kumar, Ujjwal Kaushik, Vrinda Gupta, S. Gowri, Md Faiyazuddin, Thomas J. Webster Advances in Cancer Biology Metastasis, 2026 Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive cancers (5-year survival <12%), and its complexity and great resistance to treatment are partially explained by the complex tumor microenvironment (TME). The thick desmoplastic stroma, composed of cancer-associated fibroblasts, extracellular matrix molecules, immune-suppressive cells, and an abnormal vasculature, forms physical and biochemical barriers that restrict drug delivery and immune cell invasion. The traditional treatments, which focus on one or more elements of the TME, have not been very successful, with stromal elements showing context-specific functions and dynamic interactions. As such, there is an increasing demand for integrative approaches to therapy that aim at functional remodelling rather than tumour stroma depletion. Herein, we provide a systems-level view of how engineered or smart stem cells could be used to reconstruct the PDAC microenvironment. These stem cell systems already have inbuilt tumor-homing capacity and may be genetically or bio-materials-engineered to provide therapeutic factors in a regulated, tumor-responsive manner. Some of the major pathways that participate in TME reorganization, such as fibroblast reprogramming, extracellular matrix normalization, reestablishment of vascular function, and reactivation of anti-tumor immunity, are discussed. Moreover, we present new strategies, including feedback-responsive gene circuits, cytokine delivery systems, and combination strategies that integrate stem cell therapy with other conventional treatments. Lastly, we discuss existing translation issues, including delivery efficiency, safety considerations, and differences in clinical responses, and describe future trends toward biomarker-directed and patient-centered treatment. Altogether, smart stem cell-based solutions represent a promising platform for transforming the PDAC microenvironment into a treatment-responsive and therapy-resistant role.
Alcohol-induced extracellular vesicle signatures: Exploring liquid biopsy biomarkers for early cancer detection and prognosis Neeraj Choudhary, Dinesh Kumar, Thakur Prava Jyoti, Md Moidul Islam, Suresh Babu Kondaveeti, Md Faiyazuddin, Thomas J. Webster Advances in Cancer Biology Metastasis, 2026 Alcohol intake is a significant causative factor of cancer, affecting liver, colorectal, oral/esophageal, and breast cancers. The toxicity of alcohol is due to the breakdown to acetaldehyde that damages the DNA, interferes with metabolism, and generates oxidative stress. Such alterations undermine the immune system, disrupt the surrounding tissue environment, and create the conditions for cancer development. Extracellular vesicles (EVss), small particles released by cells, are a relatively recent development as important mediators of the process in recent years. EVss are also released more and are augmented with microRNAs, mitochondrial DNA, proteins, lipids and metabolites under alcohol exposure. Signals contained in these vesicles propagate injury, cause inflammation, induce fibrosis, favor the development of new blood vessels, and facilitate the survival and proliferation of cancer cells. Notably, EVss has been observed in blood, saliva and other body fluids, which means that they can be used as non-invasive tools of non-liquid biopsy. They are not only indicators of tissue injury, but also they actively mediate cancer biology. The presented manuscript is a thorough review of alcohol-associated EV patterns in various cancers and highlights how they can be used as a biomarker in the early diagnosis, prognosis, and treatment response. EV-based markers have proven to be more sensitive and specific as compared to traditional blood tests, including AFP and CEA especially in the detection of cancer in the early stage or predicting resistance to treatment. The present literature provides a summary of alcohol-induced EVs profiles in various cancers, making them dynamic effectors of carcinogenesis as well as biomarkers with clinical relevance, but also multi-omic EVs profiles is the most appropriate compared to the conventional markers of diagnostic/prognostic markers. The priorities in the clinical translation of EVs to the clinical setting are seen in the need to come up with unit protocols that can be used to isolate and analyze EVs and develop alcohol-specific patient cohorts that can reflect genetic and lifestyle differences that affect the performance of biomarkers. To pass regulatory validation and use the multi-omic EVs in practice, it will be necessary to validate them in large, well-characterised populations. The combination of these strategies makes alcohol-induced EVs signatures some of the most effective precision oncology and personalised cancer treatment tools.
Engineering cardiac regeneration using stem cells: Cellular sources, differentiation signatures, targeted delivery, and functional recovery Sonia Gupta, Md Faiyazuddin, Vrinda Gupta, Rajni Tanwar, Pooja Rani, Wesam Taher Almagharbeh, Neeraj Choudhary, Dinesh Kumar, Thomas J. Webster Regenerative Therapy, 2026 Cardiovascular diseases remain the leading cause of mortality worldwide, and the limited regenerative capacity of the adult heart continues to delay functional recovery, resulting in myocardial injury. Stem cell-based therapies offer a promising avenue for cardiac repair through mechanisms that include cardiomyogenic differentiation, paracrine signaling, angiogenic stimulation, and immunomodulation. Although pluripotent stem cells, mesenchymal stem cells, and cardiac progenitor cells have demonstrated significant benefits in preclinical models, clinical translation has yielded modest functional improvements, mainly due to poor cell retention, electrical and structural immaturity of transplanted cells, immune-mediated clearance, and concerns regarding tumorigenicity and arrhythmogenicity. Therapeutic efficacy largely derives from extracellular vesicles, secreted microRNAs, pro-survival cytokines, and other bioactive substances released by cells. Direct replacement of cardiomyocytes is challenging because the host tissue environment limits the acceptance and stable integration of exogenous cells. Novel engineered cardiac patches, biomaterial-assisted cell delivery, gene-edited progenitor transplantation, exosome therapeutics, and cell-free therapy are improving safety, the plausibility of cell transplantation, and the precision of tissue targeting. Despite those biotech improvements, there are still significant obstacles to restoring permanent, clinically meaningful cardiac function. Regenerative stem cell and cell-free technologies will have the greatest potential for myocardial repair if integrative approaches to regenerative biology, biomaterial engineering, and immunomodulation are used.
Architected 3D‑printed microneedle composites for precision-controlled and personalized osteoporosis drug delivery Md. Jasim Uddin, Amol D. Gholap, Safiya Mohammed Saeed, Dinesh Kumar, Neeraj Choudhary, Yahya E. Choonara, Gowri Sundaram, Thomas J. Webster, Md. Faiyazuddin Advanced Composites and Hybrid Materials, 2026 The ineffectiveness of conventional therapies for osteoporosis (OP) is frequently attributed to systemic adverse effects, lack of effective targeting, and inadequate medication delivery. 3D-printed microneedles (3DMNs) used for targeted therapeutic delivery represent a transformational strategy that not only addresses these issues but also dramatically improves therapeutic results for treating chronic OP. Bibliometric analysis reveals an exponential growth in MN research, with 3,994 PubMed-indexed articles (1952–2024), of which 2,910 (~ 73%) emerged in the last five years. The use of state-of-the-art 3D printing technology to create MNs with unmatched accuracy and configurable functionality, in addition to its potential, current challenges and future directions, is at the core of this review article. By tailoring the geometry and drug content of these MNs, one can administer OP therapy at a degree of personalization that was not previously possible. This technique, in contrast to existing approaches, places a strong emphasis on localized medication delivery. With minimal invasiveness, 3DMNs can be used to penetrate the skin and deliver therapeutic payloads to afflicted osteoporotic areas precisely. Regulatory-approved MN products (e.g., MicronJet600) have validated the translational viability of the platform in vaccinology, yet their extension to OP remains nascent. This review presents a novel technological method that overcomes current constraints in drug delivery systems, adding to the continuing discussion on effective OP therapies. In addition, here, we emphasize the importance of progressive biodegradable and biocompatible materials for creating MNs that guarantee their compatibility with the complex environment of bone tissue. Positioned at the intersection of biomedical engineering and targeted drug delivery, 3DMNs represent a promising paradigm for next-generation OP therapeutics, enabling customizable, scalable, and pain-free alternatives to conventional injection-based regimens. This graphical abstract illustrates the design and fabrication of diverse microneedle types using additive manufacturing to enable precise, localized delivery of osteotropic agents, overcoming the stratum corneum barrier and minimizing systemic side effects. Emphasis is placed on mechanical robustness, biodegradable polymers, microchannel formation, and regulatory considerations, underscoring the translational potential of this prototype platform to revolutionize precision osteoporosis therapy ( Image created using a licensed version of BioRender ).
Japanese Encephalitis: Understanding Its Impact, Prevention, and the Role of Vaccination Mohd Sayeed Shaikh, Zaid Z. Khan, Shaikh Shahbaz A. Majeed, Shaikh Shoaib Iftekhar, Syed J. Imran, Md. Faiyazuddin, Sakshi Sharma, Aroop Mohanty, Sanjit Sah, Rachana Mehta, Shriyansh Srivastava, Thamir M. Alshammari, Lysien Zambrano, Juan Felipe López‐Marín, Alfonso J. Rodriguez‐Morales Reviews in Medical Virology, 2026 Japanese encephalitis (JE) is a mosquito‐borne viral disease and remains an important cause of viral encephalitis in Asia and parts of the Western Pacific. Earlier WHO‐supported global burden estimates published around 2014 suggested approximately 68,000 clinical cases and up to 20,400 deaths annually; however, the World Health Organization emphasises that the true burden of JE is difficult to quantify due to substantial underreporting and heterogeneous surveillance systems. Although vaccination programs have led to marked declines in incidence in several countries, JE transmission persists in endemic regions, and sporadic outbreaks continue to occur. In the absence of specific antiviral therapy, prevention remains the cornerstone of JE control, with vaccination representing the most effective public health intervention. Among available vaccines, the live‐attenuated SA14‐14‐2 vaccine has played a central role in reducing the burden of JE in endemic countries. Its high effectiveness, long‐term protection following a single dose, favourable safety profile, WHO prequalification, and incorporation into national immunisation programs have made it the backbone of JE prevention in Asia. Inactivated vaccines, such as IXIARO, and chimaeric vaccines, such as IMOJEV, provide important complementary options, particularly for travellers and non‐endemic populations. This review synthesises current knowledge on JE epidemiology, transmission, clinical manifestations, diagnostics, pathogenesis, and advances in vaccination strategies. By integrating recent outbreak data, immunological insights, and vaccine developments, we highlight the continued public health relevance of JE and the critical importance of sustained vaccination programs, surveillance strengthening, and equitable vaccine access to further reduce its global impact.
Stem cell-based interventions for epilepsy: Current progress and future promise Dinesh Kumar, Mehboob’s Ashraf, Vrinda Gupta, Rajni Tanwar, Thamir M. Alshammari, Md. Faiyazuddin Epileptic Disorders, 2026 Epilepsy affects millions globally, with a significant proportion of patients remaining refractory to conventional pharmacological and surgical treatments. Stem cell therapy represents a promising regenerative treatment. It can repair damaged neural networks, restore inhibitory balance, and modulate the inflammatory microenvironment characteristic of epileptic brains. Preclinical studies using diverse models, such as pilocarpine, kainic acid, and kindling have demonstrated seizure reduction, cognitive improvements, and histological repair following stem cell transplantation. Various cell types associated with stem cells, such as embryonic growth stem cells, neural growth stem cells, induced pluripotent stem cells, and mesenchymal stem cells, have been explored, each offering unique therapeutic advantages and challenges. Early clinical trials have demonstrated preliminary safety and feasibility, with encouraging trends toward seizure control and improvement in quality of life. Innovative strategies, including gene editing, preconditioning, scaffold integration, and exosome‐based therapies, are being actively developed to overcome existing translational hurdles. Personalized regenerative approaches, regulatory harmonization, and sustainable economic models are crucial for advancing stem cell therapies from experimental settings to mainstream clinical applications. With continued multidisciplinary collaboration and scientific innovation, stem cell treatment holds the caliber for redefining the assessment of the landscape of refractory epilepsy.
Introduction to Nanotechnology in Food Preservation Amol D. Gholap, Pankaj R. Khuspe, Sadikali F. Sayyad, Navnath T. Hatvate, Machindra Chavan, Md Faiyazuddin Nanotechnology in Food Packaging and Preservation Principles and Practical Applications, 2025
Lipid-based drug delivery for lungs cancer Mohd Sayeed Shaikh, Rupesh R. Kurhade, Shaikh Shahbaz A. Majeed, Jaiprakash N. Sangshetti, Md Faiyazuddin Lipids in Pulmonary Drug Delivery, 2025
Green antibacterial materials for wound dressings S. Gowri, M. Shandhiya, B. Janarthanan, S.S. Kaviya, Md. Faiyazuddin, S. Sharmila, A. Saranya Green Antibacterial Materials Eco Friendly Synthesis Performance and Applications, 2025
Lipid-based vaccines against viruses including COVID-19 Amol D. Gholap, Pankaj R. Khuspe, Md Faiyazuddin, Md Jasim Uddin, Deblina D. Bhowmik, Rushikesh P. Said, Kalyani S. Sonawane, Swapnali Parit, Navnath T. Hatvate Lipids in Pulmonary Drug Delivery, 2025
Manipulating the rhizosphere microbiome for plant health Amol D. Gholap, Sagar R. Pardeshi, Pankaj R. Khuspe, Sadikali F. Sayyad, Machindra Chavan, Navnath T. Hatvate, Md Faiyazuddin, Md Jasim Uddin Microbiome Engineering the New Dimension of Biotechnology, 2024
Omics tools for determining microbial composition: A systematic review Amol D. Gholap, Sampada D. Sawant, Sagar R. Pardeshi, Pankaj R. Khuspe, Sadikali F. Sayyad, Machindra Chavan, Navnath T. Hatvate, Md Faiyazuddin, Md Jasim Uddin Microbiome Engineering the New Dimension of Biotechnology, 2024
Advancement of Radiolabeled Exosomes in Brain Disorders Md Jasim Uddin, Md. Faiyazuddin, Jasmin Hassan, Samiha Binte Sadiq, Sumaiya Islam Khan, Afra Nawar Exosomes Based Drug Delivery Strategies for Brain Disorders, 2024
Food Biopackaging for Human Benefits: Status and Perspectives Amol D. Gholap, Sampada D. Sawant, Sadikali F. Sayyad, Navnath T. Hatvate, Machindra Chavan, Satish Rojekar, Md Faiyazuddin Biobased Packaging Materials Sustainable Alternative to Conventional Packaging Materials, 2024
Engineered artificial MicroRNA in plant: an overview Amol D. Gholap, Navnath T. Hatvate, Deblina Bhowmik, Sampada D. Sawant, Sonali A. Gholap, Kiran M. Londhe, Satish Rojekar, Md Faiyazuddin Microrna Advances and Application in Plant Biology, 2024
Addressing the resurgence of global monkeypox (Mpox) through advanced drug delivery platforms Sourav Mohanto, Md Faiyazuddin, Amol Dilip Gholap, Darshan JC, Adrija Bhunia, Kannan Subbaram, Mohammed Gulzar Ahmed, Sagnik Nag, Mohammad Shabib Akhtar, D. Katterine Bonilla-Aldana, Sanjit Sah, Sumira Malik, Zahraa Haleem Al-qaim, Joshuan J. Barboza, Ranjit Sah Travel Medicine and Infectious Disease, 2023
Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review Md. Faiyazuddin, A. Sophia, Sumel Ashique, Amol D. Gholap, S. Gowri, Sourav Mohanto, C. Karthikeyan, Sagnik Nag, Arif Hussain, Mohammad Shabib Akhtar, Md. Afroz Bakht, Mohammed Gulzar Ahmed, Sarvesh Rustagi, Alfonso J. Rodriguez-Morales, Luis Andres Salas-Matta, Aroop Mohanty, D. Katterine Bonilla-Aldana, Ranjit Sah Frontiers in Immunology, 2023
Validated HPTLC method for simultaneous quantitation of bioactive citral isomers in lemongrass oil encapsulated solid lipid nanoparticle formulation International Journal of Essential Oil Therapeutics, 2009
Phytotherapeutic potential of tea tree essential oil in vitro and emerging vistas in the skincare industry: A comprehensive review International Journal of Essential Oil Therapeutics, 2009
RECENT SCHOLAR PUBLICATIONS
Precision Pediatric Cancer Nanomedicine: Advancing Personalized Nano Therapies to Reduce Non-Communicable Diseases Through AI-Driven 3D-Printed Drugs N Choudhary, D Kumar, TP Jyoti, BG Prajapati, M Kchaou, TJ Webster, ... International Journal of Nanomedicine, 575214 , 2026 2026
Nanotechnology-driven cancer therapies for precision oncology: advances and clinical outlook V Gupta, D Kumar, S Gupta, R Tanwar, NK Jaiswal, MM Islam, S Singh, ... International Journal of Nanomedicine, 568254 , 2026 2026 Citations: 5
Next 5 years in autoimmunity: predictive diagnostics, immune signatures, and personalized immune therapy A Usmani, MA Siddiqui, D Kumar, S Gowri, TJ Webster, M Faiyazuddin International Immunopharmacology 179, 116530 , 2026 2026
Precision Breast Oncology: Molecular Insights and Transformative Clinical Strategies TJW Bindiya Chauhan, Dinesh Kumar, Anas Ahmad, Ziyaul Haque, Mirza Salman ... Cancer Treatment and Research Communications, 101242 , 2026 2026
Reprogramming the Pancreatic Tumor Microenvironment Using Smart Stem Cells: A New Frontier in Cancer Therapy TB Khan, N Choudhary, S Sharma, D Kumar, U Kaushik, V Gupta, ... Advances in Cancer Biology-Metastasis, 100188 , 2026 2026
A Comprehensive Review of the Revolutionary Potential of Blockchain in Safe, Secure, and Sustainable Pharmaceutical Operations M Faiyazuddin, K Moharir, AD Gholap, PR Christodoss, YE Choonara, ... Pharmaceutical Research, 1-47 , 2026 2026
Architected 3D‑printed microneedle composites for precision-controlled and personalized osteoporosis drug delivery MJ Uddin, AD Gholap, SM Saeed, D Kumar, N Choudhary, YE Choonara, ... Advanced Composites and Hybrid Materials , 2026 2026
Computational identification of Terminalia arjuna phytochemicals as potential 3α-HSD3 inhibitors MA Al Mashud, MA Rahman, A Kumer, S Rahman, MA Awon, TJ Webster, ... Scientific Reports 16 (1), 8045 , 2026 2026
Japanese Encephalitis: Understanding Its Impact, Prevention, and the Role of Vaccination MS Shaikh, ZZ Khan, SSA Majeed, SS Iftekhar, SJ Imran, M Faiyazuddin, ... Reviews in Medical Virology 36 (2), e70123 , 2026 2026
Alcohol-Induced Extracellular Vesicle Signatures: Exploring Liquid Biopsy Biomarkers for Early Cancer Detection and Prognosis N Choudhary, D Kumar, TP Jyoti, MM Islam, SB Kondaveeti, ... Advances in Cancer Biology-Metastasis, 100176 , 2026 2026
Real-World Application of AI in Nanotechnology AD Gholap, PR Khuspe, D Mane, M Faiyazuddin Artificial Intelligence in Nanotechnology: Advanced Drug Delivery and … , 2026 2026
Tissue Culture Techniques in Crop Improvement AD Gholap, PR Khuspe, SF Sayyad, M Chavan, NT Hatvate, RD Bhusal, ... Technological Advancements in Sustainable Crop Improvement and Production … , 2026 2026
Progress and Innovation in Japanese Encephalitis Vaccines: Toward Global Immunization MS Shaikh, TM AlShammari, D Kumar, M Faiyazuddin Recent Advances in Anti-Infective Drug Discovery , 2026 2026
Green Synthesis of ZnO Nanoparticles Using Antidesma orthogyne Extract and Their Antimicrobial and Cytotoxic Activities M Taher, NM Nik Abd Rahman Zaki, J Md Jaffri, D Susanti, J Khotib, ... Nanochemistry Research 11 (1), 152-168 , 2026 2026
Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management MS Shaikh, RR Kurhade, AAM Siddiqui, SSA Majeed, TJ Webster, ... ChemBioChem 27 (1), e202500676 , 2026 2026 Citations: 4
Advances in 3D Printed Microneedles as a Prototype for Skin Targeted Therapeutics in Personalized Dermal Pharmaceuticals MJ Uddin, MS Baig, AD Gholap, JT Khan, IA Sheikh, YE Choonara, ... AAPS PharmSciTech 27 (1), 49 , 2026 2026 Citations: 5
Green antibacterial materials for wound dressings S Gowri, M Shandhiya, B Janarthanan, SS Kaviya, M Faiyazuddin, ... Green Antibacterial Materials, 85-113 , 2026 2026
innovations in ocular drug MS Baig¹, SK Karade, A Ahmad, M Faiyazuddin10, NH Al-Qahtani The Road toward Nano-Based Diagnostics for Health and Disease, 56 , 2025 2025
Mesalamine and Ascorbic Acid Drug–Drug Cocrystal-Loaded Suppositories: A Coadministrative Approach for Localized Treatment of Ulcerative Colitis H Desai, N Gulhane, G Bhave, B Chatale, P Shah, YI Asiri, MZ Hassan, ... Journal of Pharmaceutical Innovation 20 (6), 278 , 2025 2025 Citations: 1
MOST CITED SCHOLAR PUBLICATIONS
The impact of artificial intelligence on healthcare: a comprehensive review of advancements in diagnostics, treatment, and operational efficiency M Faiyazuddin, SJQ Rahman, G Anand, RK Siddiqui, R Mehta, MN Khatib, ... Health science reports 8 (1), e70312 , 2025 2025 Citations: 233
Advances in artificial intelligence for drug delivery and development: a comprehensive review AD Gholap, MJ Uddin, M Faiyazuddin, A Omri, S Gowri, M Khalid Computers in Biology and Medicine 178, 108702 , 2024 2024 Citations: 205
Critical steps and energetics involved in a successful development of a stable nanoemulsion A Qadir, MD Faiyazuddin, MDT Hussain, TM Alshammari, F Shakeel Journal of Molecular Liquids 214, 7-18 , 2016 2016 Citations: 147
Anti-inflammatory and antioxidant activity of Ficus carica Linn. leaves B Ali, M Mujeeb, V Aeri, SR Mir, M Faiyazuddin, F Shakeel Natural product research 26 (5), 460-465 , 2012 2012 Citations: 142
Evaluation of antihepatotoxic potential of Solanum xanthocarpum fruit extract against antitubercular drugs induced hepatopathy in experimental rodents T Hussain, RK Gupta, K Sweety, MS Khan, MS Hussain, MD Arif, ... Asian Pacific journal of tropical biomedicine 2 (6), 454-460 , 2012 2012 Citations: 99
Phytotherapeutic potential and pharmaceutical impact of Phoenix dactylifera (date palm): current research and future prospects A Qadir, F Shakeel, A Ali, M Faiyazuddin Journal of food science and technology 57 (4), 1191-1204 , 2020 2020 Citations: 93
Hepatoprotective effect of Solanum xanthocarpum fruit extract against CCl4 induced acute liver toxicity in experimental animals RK Gupta, T Hussain, G Panigrahi, A Das, GN Singh, K Sweety, ... Asian Pacific journal of tropical medicine 4 (12), 964-968 , 2011 2011 Citations: 91
Transdermal and topical delivery of anti-inflammatory agents using nanoemulsion/microemulsion: an updated review F Shakeel, W Ramadan, MS Faisal, M Rizwan, M Faiyazuddin, G Mustafa, ... Current nanoscience 6 (2), 184-198 , 2010 2010 Citations: 61
Biogenic synthesis of Nickel Oxide Nanoparticles using Averrhoa bilimbi and Investigation of its Antibacterial, Antidiabetic and Cytotoxic properties V Haritha, S Gowri, B Janarthanan, M Faiyazuddin, C Karthikeyan, ... Inorganic Chemistry Communications 144, 109930 , 2022 2022 Citations: 57
Harnessing nanovaccines for effective immunization─ a special concern on COVID-19: facts, fidelity, and future prospective AD Gholap, J Gupta, P Kamandar, DD Bhowmik, S Rojekar, ... ACS biomaterials science & engineering 10 (1), 271-297 , 2023 2023 Citations: 53
A validated HPTLC method for determination of terbutaline sulfate in biological samples: Application to pharmacokinetic study M Faiyazuddin, A Rauf, N Ahmad, S Ahmad, Z Iqbal, S Talegaonkar, ... Saudi Pharmaceutical Journal 19 (3), 185-191 , 2011 2011 Citations: 53
Lipid-Based Nanoparticles: Innovations in Ocular Drug Delivery MS Baig, SK Karade, A Ahmad, MA Khan, A Haque, TJ Webster, ... Frontiers in Molecular Biosciences 11, 1421959 , 2024 2024 Citations: 46
Environmental implications and nanotechnological advances in octocrylene-enriched sunscreen formulations: a comprehensive review AD Gholap, SR Pardeshi, NT Hatvate, N Dhorkule, SF Sayyad, ... Chemosphere 358, 142235 , 2024 2024 Citations: 45
Silymarin: an insight to its formulation and analytical prospects U Ahmad, M Faiyazuddin, MT Hussain, S Ahmad, T M Alshammari, ... Acta physiologiae plantarum 37 (11), 253 , 2015 2015 Citations: 43
Antiarthritic Potential of Calotropis procera Leaf Fractions in FCA-Induced Arthritic Rats: Involvement of Cellular Inflammatory Mediators and Other Biomarkers VS Singh, SC Dhawale, F Shakeel, M Faiyazuddin, S Alshehri Agriculture 11 (1), 68 , 2021 2021 Citations: 42
Nanoengineered chitosan functionalized titanium dioxide biohybrids for bacterial infections and cancer therapy M Shabib Akhtar, K Chandrasekaran, S Saminathan, SR Rajalingam, ... Scientific Reports 14 (1), 3705 , 2024 2024 Citations: 41
A Handbook of Artificial Intelligence in Drug Delivery AK Philip, A Shahiwala, M Rashid, M Faiyazuddin (No Title) 1, 623 (ISBN: 978-0-323-89925-3) , 2023 2023 Citations: 39
Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions MS Shaikh, M Faiyazuddin, MS Khan, SK Pathan, IJ Syed, AD Gholap, ... Frontiers in Microbiology 15, 1413250 , 2024 2024 Citations: 38
Nanopharmaceuticals: Principles and Applications Vol. 2 VK Yata, S Ranjan, N Dasgupta, E Lichtfouse Springer , 2020 2020 Citations: 37
Addressing the resurgence of global monkeypox (Mpox) through advanced drug delivery platforms S Mohanto, M Faiyazuddin, AD Gholap, D Jc, A Bhunia, K Subbaram, ... Travel Medicine and Infectious Disease 56, 102636 , 2023 2023 Citations: 36
